Form 8-K - Current report:
SEC Accession No. 0000950170-25-021801
Filing Date
2025-02-18
Accepted
2025-02-18 07:06:04
Documents
60
Period of Report
2025-02-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20250218.htm   iXBRL 8-K 48326
2 EX-99.1 axsm-ex99_1.htm EX-99.1 283914
3 EX-99.2 axsm-ex99_2.htm EX-99.2 46081
4 GRAPHIC img36028404_0.jpg GRAPHIC 66512
5 GRAPHIC axsm-ex99_2s1.jpg GRAPHIC 358568
6 GRAPHIC axsm-ex99_2s2.jpg GRAPHIC 896630
7 GRAPHIC axsm-ex99_2s3.jpg GRAPHIC 433232
8 GRAPHIC axsm-ex99_2s4.jpg GRAPHIC 417131
9 GRAPHIC axsm-ex99_2s5.jpg GRAPHIC 237405
10 GRAPHIC axsm-ex99_2s6.jpg GRAPHIC 245745
11 GRAPHIC axsm-ex99_2s7.jpg GRAPHIC 321993
12 GRAPHIC axsm-ex99_2s8.jpg GRAPHIC 284212
13 GRAPHIC axsm-ex99_2s9.jpg GRAPHIC 273815
14 GRAPHIC axsm-ex99_2s10.jpg GRAPHIC 389780
15 GRAPHIC axsm-ex99_2s11.jpg GRAPHIC 403757
16 GRAPHIC axsm-ex99_2s12.jpg GRAPHIC 280960
17 GRAPHIC axsm-ex99_2s13.jpg GRAPHIC 263604
18 GRAPHIC axsm-ex99_2s14.jpg GRAPHIC 235626
19 GRAPHIC axsm-ex99_2s15.jpg GRAPHIC 285528
20 GRAPHIC axsm-ex99_2s16.jpg GRAPHIC 318302
21 GRAPHIC axsm-ex99_2s17.jpg GRAPHIC 352047
22 GRAPHIC axsm-ex99_2s18.jpg GRAPHIC 232429
23 GRAPHIC axsm-ex99_2s19.jpg GRAPHIC 324033
24 GRAPHIC axsm-ex99_2s20.jpg GRAPHIC 364500
25 GRAPHIC axsm-ex99_2s21.jpg GRAPHIC 256299
26 GRAPHIC axsm-ex99_2s22.jpg GRAPHIC 318253
27 GRAPHIC axsm-ex99_2s23.jpg GRAPHIC 356870
28 GRAPHIC axsm-ex99_2s24.jpg GRAPHIC 208285
29 GRAPHIC axsm-ex99_2s25.jpg GRAPHIC 384318
30 GRAPHIC axsm-ex99_2s26.jpg GRAPHIC 319673
31 GRAPHIC axsm-ex99_2s27.jpg GRAPHIC 306398
32 GRAPHIC axsm-ex99_2s28.jpg GRAPHIC 278406
33 GRAPHIC axsm-ex99_2s29.jpg GRAPHIC 347416
34 GRAPHIC axsm-ex99_2s30.jpg GRAPHIC 290549
35 GRAPHIC axsm-ex99_2s31.jpg GRAPHIC 323655
36 GRAPHIC axsm-ex99_2s32.jpg GRAPHIC 287664
37 GRAPHIC axsm-ex99_2s33.jpg GRAPHIC 346956
38 GRAPHIC axsm-ex99_2s34.jpg GRAPHIC 342771
39 GRAPHIC axsm-ex99_2s35.jpg GRAPHIC 323573
40 GRAPHIC axsm-ex99_2s36.jpg GRAPHIC 341234
41 GRAPHIC axsm-ex99_2s37.jpg GRAPHIC 266840
42 GRAPHIC axsm-ex99_2s38.jpg GRAPHIC 374663
43 GRAPHIC axsm-ex99_2s39.jpg GRAPHIC 260302
44 GRAPHIC axsm-ex99_2s40.jpg GRAPHIC 293700
45 GRAPHIC axsm-ex99_2s41.jpg GRAPHIC 343008
46 GRAPHIC axsm-ex99_2s42.jpg GRAPHIC 242835
47 GRAPHIC axsm-ex99_2s43.jpg GRAPHIC 359162
48 GRAPHIC axsm-ex99_2s44.jpg GRAPHIC 360504
49 GRAPHIC axsm-ex99_2s45.jpg GRAPHIC 323340
50 GRAPHIC axsm-ex99_2s46.jpg GRAPHIC 117018
  Complete submission text file 0000950170-25-021801.txt   21122753

Data Files

Seq Description Document Type Size
51 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20250218.xsd EX-101.SCH 23858
62 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20250218_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 25632716
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)